Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-03-30EMA Authorised: Finlee (dabrafenib mesilate) — Novartis Europharm Limited
The European Medicines Agency has authorised Finlee (dabrafenib mesilate). The medicine is indicated for glioma and has orphan medicine desi…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures [NA]
This clinical trial compares intradermal running sutures with transdermal interrupted sutures for skin closure in oncologic neurosurgical pr…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Hyperpolarized Imaging in Diagnosing Participants With Glioma [Phase 1]
Phase 1 clinical trial evaluating hyperpolarized imaging to help diagnose glioma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma [NA]
A Mayo Clinic-sponsored clinical trial is evaluating a digital platform for delivering home-based sequential therapy in patients with glioma…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab [Phase 2]
Phase II trial evaluating pulsed reduced-dose-rate radiation therapy with bevacizumab for glioma. The study was terminated and results have …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: FIH Clinical Investigation of Graphene Electrodes for Brain Mapping [NA]
A first-in-human clinical investigation of graphene electrodes for brain mapping is recruiting, sponsored by the University of Manchester. C…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis [Phase 1]
Phase 1 clinical trial evaluating intratumoral microdialysis to characterize abemaciclib neuropharmacokinetics in diffuse midline glioma.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma [Phase 1, Phase 2]
Clinical trial update for Ad-TD-nsIL12, an oncolytic virus, in primary high-grade glioma, currently in Phase 1/Phase 2 and enrolling by invi…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Language Network Prehab Via fMRI Neurofeedback [NA]
A Yale University clinical trial is exploring language-network prehabilitation using fMRI neurofeedback for glioma patients and those underg…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study for Cerebral Open Flow Microperfusion [NA]
A Mayo Clinic study evaluating cerebral open flow microperfusion for glioma and glioblastoma is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption [NA]
This completed study evaluated the safety and feasibility of ExAblate–mediated blood-brain barrier disruption in glioma and glioblastoma.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases [EARLY_Phase 1]
This EARLY_PHASE1 trial evaluating ketoconazole before surgery in patients with recurrent glioma or breast cancer brain metastases was termi…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma [Phase 1]
This is a Phase 1 safety and dose-finding trial of GLIX1 in adults with recurrent or progressive high-grade glioma, currently not yet recrui…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies [Phase 4]
Phase 4 trial evaluating olutasidenib for drug-drug interaction in IDH1-mutant malignancies. The study is currently recruiting in AML, gliom…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications [Phase 1, Phase 2]
Clinical trial update for PLX038 in primary CNS tumors with MYC or MYCN amplification; Phase 1/2 studies are currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas [Phase 1]
Phase 1 trial assessing the safety of combining fluvastatin with celecoxib in glioma (optico-chiasmatic) has completed, focusing on safety a…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas [NA]
A completed trial evaluating temporally-modulated pulsed radiation therapy after prior EBRT in adults with recurrent IDH-mutant gliomas, inc…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: 99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging [NA]
A clinical trial update describes an active-not-recruiting study at Tomsk National Research Medical Center comparing 99mTc-1-thio-D-glucose …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3 [Phase 1]
A Phase 1 study by Boehringer Ingelheim is testing how well different doses of BI 764532 are tolerated in DLL3-positive glioma patients; the…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS) [NA]
A clinical trial evaluating neuromodulation to prehabilitate cortical function in patients with high-grade glioma near motor pathways, using…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma [NA]
A clinical trial of Vorasidenib guided by AGX PET in recurrent and low-grade glioma is not yet recruiting, with Huashan Hospital listed as s…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Quality of Life and Neurocognitive Functioning [NA]
Completed clinical trial update examining quality of life and neurocognitive functioning in glioma patients.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma [NA]
First-in-human study of the CIPHER System during brain surgery for newly diagnosed glioma; the trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: WBSI Guided Personalized Delivery of TTFields [NA]
This clinical trials entry reports that a Penn Medicine Abramson Cancer Center study evaluating WBSI-guided, personalized delivery of tumor-…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: ABY-029 Glioma Trial [Phase 1]
A Phase 1 clinical trial update for ABY-029 in glioma (intracranial tumor) is currently recruiting.